质子治疗脑坏死体积与生存分析:混合治愈模型
本研究回顾性分析179例接受质子治疗(处方剂量≥59.4 Gy(RBE))且非靶脑受中等至高剂量照射的患者,采用混合治愈模型构建正常组织并发症概率(NTCP)模型。研究发现等效均匀剂量(EUD,a=9)是症状性放射性脑坏死的最强独立预测因子,颅内肿瘤D50=57.7 Gy,颅外肿瘤D50=39.5 Gy,γ50=2.5。
要点
- EUD(a=9)是质子治疗后脑坏死的独立强预测因子。
- 颅内肿瘤NTCP模型D50=57.7 Gy,颅外肿瘤D50=39.5 Gy。
- 原发肿瘤位置与EUD共同预测脑坏死风险。
核心结论
- EUD是质子治疗脑坏死的独立强预测因子,原发肿瘤位置亦为显著预测因素。
研究设计与样本
- 回顾性分析179例头颈、颅底或颅内肿瘤质子治疗患者,处方剂量≥59.4 Gy(RBE),非靶脑受中等至高剂量照射。
- 采用混合治愈模型拟合无坏死生存,并构建Logistic NTCP模型,调整潜在混杂因素。
主要发现
- 179例中颅内肿瘤83例,颅外原发肿瘤96例。
- 描述脑坏死的最佳剂量指标为EUD(a=9)。
- Logistic NTCP模型拟合参数:颅内肿瘤D50=57.7 Gy,颅外肿瘤D50=39.5 Gy,两者γ50=2.5。
- 多因素分析显示EUD和原发肿瘤位置是脑坏死最强预测因子。
关键数值与推荐
- 颅内肿瘤NTCP模型D50=57.7 Gy,颅外肿瘤D50=39.5 Gy,γ50=2.5。
- EUD参数a=9为描述脑坏死的最佳剂量指标。
临床怎么用
- 质子治疗计划评估时可考虑使用EUD(a=9)预测症状性放射性脑坏死风险。
- 颅内与颅外肿瘤患者应参考不同D50值(57.7 Gy vs 39.5 Gy)进行NTCP模型风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: High-dose fractionated radiotherapy is often necessary to achieve long-term tumor control in several types of tumors involving or within close proximity to the brain. There is limited data to guide on optimal constraints to the adjacent nontarget brain. This investigation explored the significance of the three-dimensional (3D) dose distribution of passive scattering proton therapy to the brain with other clinicopathological factors on the development of symptomatic radiation necrosis. MATERIALS AND METHODS: All patients with head and neck, skull base, or intracranial tumors who underwent proton therapy (minimum prescription dose of 59.4 Gy(RBE)) with collateral moderate to high dose radiation exposure to the nontarget brain were retrospectively reviewed. A mixture cure model with respect to necrosis-free survival was used to derive estimates for the normal tissue complication probability (NTCP) model while adjusting for potential confounding factors. RESULTS: Of 179 identified patients, 83 patients had intracranial tumors and 96 patients had primary extracranial tumors. The optimal dose measure obtained to describe the occurrence of radiation necrosis was the equivalent uniform dose (EUD) with parameter a = 9. The best-fit parameters of logistic NTCP models revealed D50 = 57.7 Gy for intracranial tumors, D50 = 39.5 Gy for extracranial tumors, and γ50 = 2.5 for both tumor locations. Multivariable analysis revealed EUD and primary tumor location to be the strongest predictors of brain radiation necrosis. CONCLUSION: In the current clinical volumetric data analyses with multivariable modelling, EUD was identified as an independent and strong predictor for brain radiation necrosis from proton therapy.
引用
- Niyazi M, Niemierko A, Paganetti H, et al. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. Radiother Oncol. 2019. PMID: 31563411. doi:10.1016/j.radonc.2019.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。